insights_auto
Why is ARGNF down 15.58%?
Dive Deeperchevron_right
ARGNF:OTCMKTS
argenx SE
$790.15
arrow_downward
-15.58%(-145.85) 1D
Oct 13, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARGNF...
Open
$790.15
High
$790.15
Low
$790.15
Mkt. cap
51.03B
Avg. vol.
14.00
Volume
30.00
52-wk high
$1,020.00
52-wk low
$708.72
Beta
0.46
Shares outstanding
62.89M
No. of employees
2K
Open
$790.15
High
$790.15
Low
$790.15
Mkt. cap
51.03B
Avg. vol.
14.00
Volume
30.00
52-wk high
$1,020.00
52-wk low
$708.72
Beta
0.46
Shares outstanding
62.89M
No. of employees
2K
News stories
From web sources and news partners
ad-hoc-news.de
·
2 hours ago
Argenx stock pre-market at EUR 718.20
ad-hoc-news.de
·
20 hours ago
Baird cuts target for Argenx stock to USD 823.00
ad-hoc-news.de
·
2 days ago
Argenx halts UNITY study. Argenx stock trades 1.18 percent higher
WSJ
·
5 days ago
Argenx Shares Plunge After Autoimmune-Disease Trial Halt
Profile
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
About argenx SE